Clonazepam

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Watson Pharmaceuticals

Approval Status:

Approved January 1998

Specific Treatments:

anticonvulsant

Therapeutic Areas

Neurology
Family Medicine
Genetic Disease

Find Related Trials for The Following Conditions

Seizure Disorders

General Information

Clonazepam has been approved as an anticonvulsant to be manufactured in 0.5mg, 1mg and 2mg tablets. It is the generic equivalent of Roche Laboratories' Klonopin.